ArticleCancer biology & therapy2018

Induction of anaplastic lymphoma kinase (ALK) as a novel mechanism of EGFR inhibitor resistance in head and neck squamous cell carcinoma patient-derived models.

Xiaoming Ouyang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.